New danger? Popular weight loss drugs and diabetes medications may trigger permanent eye damage! New study raises serious ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...

Wellcome, a major London-based charity, is exploring options to support science and research, given cuts to health and research funding led by the United States, its chief executive said on Wednesday.

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

At the moment there's no word on job losses that may occur as a result of the reorganisation, but it has already claimed three senior executives, including chief medical officer John Tsai who is ...

Manager John Delano focuses on growing companies ... fueled by strong showings from top-10 holdings Alphabet, Meta, and Novo Nordisk, as well as a much-lesser-known name also in the top 10 ...

Novo Nordisk’s global head of business development and M&A, John MacDonald, put it another way. "It can't get any worse. It's going to go up from here, but by how much remains to be seen,” he ...